Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains

<p>Abstract</p> <p>Background</p> <p>Homologous recombination mediated by the λ-Red genes is a common method for making chromosomal modifications in <it>Escherichia coli</it>. Several protocols have been developed that differ in the mechanisms by which DNA,...

Full description

Bibliographic Details
Main Authors: Penn Charles W, Pallen Mark J, Heurlier Karin, Bingle Lewis EH, Lee David J, Busby Stephen JW, Hobman Jon L
Format: Article
Language:English
Published: BMC 2009-12-01
Series:BMC Microbiology
Online Access:http://www.biomedcentral.com/1471-2180/9/252
_version_ 1818823488285179904
author Penn Charles W
Pallen Mark J
Heurlier Karin
Bingle Lewis EH
Lee David J
Busby Stephen JW
Hobman Jon L
author_facet Penn Charles W
Pallen Mark J
Heurlier Karin
Bingle Lewis EH
Lee David J
Busby Stephen JW
Hobman Jon L
author_sort Penn Charles W
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Homologous recombination mediated by the λ-Red genes is a common method for making chromosomal modifications in <it>Escherichia coli</it>. Several protocols have been developed that differ in the mechanisms by which DNA, carrying regions homologous to the chromosome, are delivered into the cell. A common technique is to electroporate linear DNA fragments into cells. Alternatively, DNA fragments are generated <it>in vivo </it>by digestion of a donor plasmid with a nuclease that does not cleave the host genome. In both cases the λ-Red gene products recombine homologous regions carried on the linear DNA fragments with the chromosome. We have successfully used both techniques to generate chromosomal mutations in <it>E. coli </it>K-12 strains. However, we have had limited success with these λ-Red based recombination techniques in pathogenic <it>E. coli </it>strains, which has led us to develop an enhanced protocol for recombineering in such strains.</p> <p>Results</p> <p>Our goal was to develop a high-throughput recombineering system, primarily for the coupling of genes to epitope tags, which could also be used for deletion of genes in both pathogenic and K-12 <it>E. coli </it>strains. To that end we have designed a series of donor plasmids for use with the λ-Red recombination system, which when cleaved <it>in vivo </it>by the I-SceI meganuclease generate a discrete linear DNA fragment, allowing for C-terminal tagging of chromosomal genes with a 6 × His, 3 × FLAG, 4 × ProteinA or GFP tag or for the deletion of chromosomal regions. We have enhanced existing protocols and technologies by inclusion of a cassette conferring kanamycin resistance and, crucially, by including the <it>sacB </it>gene on the donor plasmid, so that all but true recombinants are counter-selected on kanamycin and sucrose containing media, thus eliminating the need for extensive screening. This method has the added advantage of limiting the exposure of cells to the potential damaging effects of the λ-Red system, which can lead to unwanted secondary alterations to the chromosome.</p> <p>Conclusion</p> <p>We have developed a counter-selective recombineering technique for epitope tagging or for deleting genes in <it>E. coli</it>. We have demonstrated the versatility of the technique by modifying the chromosome of the enterohaemorrhagic O157:H7 (EHEC), uropathogenic CFT073 (UPEC), enteroaggregative O42 (EAEC) and enterotoxigenic H10407 (ETEC) <it>E. coli </it>strains as well as in K-12 laboratory strains.</p>
first_indexed 2024-12-18T23:40:46Z
format Article
id doaj.art-974eead8b8d64b09980336fb2ffe226c
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-12-18T23:40:46Z
publishDate 2009-12-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-974eead8b8d64b09980336fb2ffe226c2022-12-21T20:47:24ZengBMCBMC Microbiology1471-21802009-12-019125210.1186/1471-2180-9-252Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strainsPenn Charles WPallen Mark JHeurlier KarinBingle Lewis EHLee David JBusby Stephen JWHobman Jon L<p>Abstract</p> <p>Background</p> <p>Homologous recombination mediated by the λ-Red genes is a common method for making chromosomal modifications in <it>Escherichia coli</it>. Several protocols have been developed that differ in the mechanisms by which DNA, carrying regions homologous to the chromosome, are delivered into the cell. A common technique is to electroporate linear DNA fragments into cells. Alternatively, DNA fragments are generated <it>in vivo </it>by digestion of a donor plasmid with a nuclease that does not cleave the host genome. In both cases the λ-Red gene products recombine homologous regions carried on the linear DNA fragments with the chromosome. We have successfully used both techniques to generate chromosomal mutations in <it>E. coli </it>K-12 strains. However, we have had limited success with these λ-Red based recombination techniques in pathogenic <it>E. coli </it>strains, which has led us to develop an enhanced protocol for recombineering in such strains.</p> <p>Results</p> <p>Our goal was to develop a high-throughput recombineering system, primarily for the coupling of genes to epitope tags, which could also be used for deletion of genes in both pathogenic and K-12 <it>E. coli </it>strains. To that end we have designed a series of donor plasmids for use with the λ-Red recombination system, which when cleaved <it>in vivo </it>by the I-SceI meganuclease generate a discrete linear DNA fragment, allowing for C-terminal tagging of chromosomal genes with a 6 × His, 3 × FLAG, 4 × ProteinA or GFP tag or for the deletion of chromosomal regions. We have enhanced existing protocols and technologies by inclusion of a cassette conferring kanamycin resistance and, crucially, by including the <it>sacB </it>gene on the donor plasmid, so that all but true recombinants are counter-selected on kanamycin and sucrose containing media, thus eliminating the need for extensive screening. This method has the added advantage of limiting the exposure of cells to the potential damaging effects of the λ-Red system, which can lead to unwanted secondary alterations to the chromosome.</p> <p>Conclusion</p> <p>We have developed a counter-selective recombineering technique for epitope tagging or for deleting genes in <it>E. coli</it>. We have demonstrated the versatility of the technique by modifying the chromosome of the enterohaemorrhagic O157:H7 (EHEC), uropathogenic CFT073 (UPEC), enteroaggregative O42 (EAEC) and enterotoxigenic H10407 (ETEC) <it>E. coli </it>strains as well as in K-12 laboratory strains.</p>http://www.biomedcentral.com/1471-2180/9/252
spellingShingle Penn Charles W
Pallen Mark J
Heurlier Karin
Bingle Lewis EH
Lee David J
Busby Stephen JW
Hobman Jon L
Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
BMC Microbiology
title Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
title_full Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
title_fullStr Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
title_full_unstemmed Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
title_short Gene doctoring: a method for recombineering in laboratory and pathogenic <it>Escherichia coli </it>strains
title_sort gene doctoring a method for recombineering in laboratory and pathogenic it escherichia coli it strains
url http://www.biomedcentral.com/1471-2180/9/252
work_keys_str_mv AT penncharlesw genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT pallenmarkj genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT heurlierkarin genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT binglelewiseh genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT leedavidj genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT busbystephenjw genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains
AT hobmanjonl genedoctoringamethodforrecombineeringinlaboratoryandpathogenicitescherichiacoliitstrains